Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Nitroglycerin for Vasoreactivity in PAH
NCT07214129Completed
- Sponsor
- Mansoura University
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nitroglycerin in pulmonary arterial hypertension (PAH), sponsored by Mansoura University. Primary endpoint: Acute Hemodynamic Response to Nebulized Nitroglycerin at 15 minutes. Started Mar 2022; status: completed.
02
Drugs
nitroglycerin
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT07214129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214129.